SeanIsaacSavitzMD

Neurology • Houston, TX

Vascular Neurology

Professor and Frank M. Yatsu Chair in Neurology and Director, Institute for Stroke and Cerebrovascular Disease

Join to view full profile

Dr. Savitz is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Savitz's full profile

Already have an account?

Office
UTHealth-Houston (Stroke Institute)
6410 Fannin St. Ste 1010
Houston, TX 77030
Phone+1 713-500-7092

Fax+1 713-500-7101

Education & Training

Beth Israel Deaconess Medical Center/Harvard Medical SchoolResidency, Neurology, 2001 - 2004
Beth Israel Deaconess Medical CenterInternship, Internal Medicine, 2000 - 2001
Albert Einstein College of MedicineClass of 2000

Certifications & Licensure

TX State Medical License 2007 - 2024
MA State Medical License 2004 - 2007
American Board of Psychiatry and Neurology Neurology
American Board of Psychiatry and Neurology Vascular Neurology

Clinical Trials

Safety/Feasibility of Autologous Mononuclear Bone Marrow Cells in Stroke Patients Start of enrollment: 2009 Jan 01
Completed
Phase 1
Safety of Intravenous Thrombolysis for Wake-up Stroke Start of enrollment: 2010 Jul 01
Completed
Phase 2
Mesenchymal Stromal Cells for Ischemic Stroke Start of enrollment: 2016 Dec 01
Withdrawn
Phase 1, Phase 2
A Study of NCS-01 in Patients With Acute Ischemic Stroke Start of enrollment: 2020 Feb 27
Recruiting
Phase 1, Phase 2
Virtually Assisted Home Rehabilitation After Acute STroke (VAST-rehab) Start of enrollment: 2020 Apr 20
Completed
Not Applicable
Roles: Principal Investigator, Contact
CompARing Long terM Outcomes in Chronic Stroke Survivors Across Investigational Assessments Following a Prescribed Upper Extremity Exercise Program Start of enrollment: 2023 Feb 21
Recruiting
Not Applicable
Roles: Principal Investigator, Contact
Validation of Early Prognostic Data for Recovery Outcome After Stroke for Future, Higher Yield Trials Start of enrollment: 2022 Jun 18
Recruiting
Roles: Principal Investigator, Contact
intenSive UpPer Extremity Recovery Program for Chronic Stroke (SUPER) Start of enrollment: 2023 Mar 20
Recruiting
Not Applicable
Roles: Contact, Principal Investigator
Virtually Assisted Home Rehabilitation After Acute Stroke-2 Start of enrollment: 2023 Mar 09
Completed
Not Applicable
Roles: Principal Investigator, Contact
Biomarkers for Vascular Contributions to Cognitive Impairment and Dementia Consortium Start of enrollment: 2021 Sep 29
Recruiting
Roles: Contact
Non-invasive Trigeminal and Vagus Nerve Stimulation for Stroke Subjects With Chronic Upper Extremity Deficits Start of enrollment: 2024 Mar 05
Recruiting
Not Applicable
Roles: Principal Investigator, Contact
Join now to see all

Publications & Presentations

PubMed

977 citations
Update of the Stroke Therapy Academic Industry Roundtable Preclinical Recommendations
Marc Fisher, Giora Z. Feuerstein, David W. Howells, Patricia D. Hurn, Thomas A. Kent
Stroke. 2009-06-01
15 citations
Efficacy of prophylactic antibiotic therapy in spinal surgery: a meta-analysis.
Martin H. Savitz, Leonard I. Malis, Sean I Savitz
Neurosurgery. 2003-07-01
352 citations
Erythropoietin administration protects retinal neurons from acute ischemia-reperfusion injury
Anna K. Junk, Antonios Mammis, Sean I Savitz, Manjeet Singh, Steven Roth
Proceedings of the National Academy of Sciences of the United States of America. 2002-08-06

Abstracts/Posters

Assessment and Reduction of Unnecessary Thrombophilia Testing in Patients 18-60 Years with Acute Cryptogenic Ischemic Stroke
Sean.I. Savitz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

Cell Society 2nd Annual Clinical Meeting
Medical Education Advocates, Coronado, California - 2/17/2012
Discussant
Houston, TX - 2/13/2014

Other

Locked-in syndrome
Savitz SI, Caplan LR
http://www.uptodate.com/contents/locked-in-syndrome
UpToDate, Wolters Kluwer Health - 2013-03-07

Press Mentions

Athersys Provides MultiStem Clinical UpdateJanuary 9th, 2023
Sharrief Awarded $3.1M NIH Grant to Test Whether Telehealth Improves Racial Disparities in Outcomes for Stroke SurvivorsDecember 6th, 2021
COVID Help Desk: What Is COVID Brain Fog, and How Do I Know if I Have It?May 19th, 2021
Join now to see all

Grant Support

Cytoprotection With Autologous Mononuclear Cells For StrokeNational Institute Of Neurological Disorders And Stroke2011–2012
Safety/Feasibility Of Autologous Mononuclear Bone Marrow Cells In Stroke PatientsEunice Kennedy Shriver National Institute Of Child Health &Human Development2010–2011
Career DevelopmentNational Institute Of Neurological Disorders And Stroke2008–2011
Preclinical Development Of Bone Marrow Mononuclear Cell Therapy For Ischemic StroNational Institute Of Neurological Disorders And Stroke2008–2009